Evaluation of the Targeted Screening of Type 2 Diabetes by Capillary Blood Glucose (Sainté Diabète)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02440555|
Recruitment Status : Completed
First Posted : May 12, 2015
Last Update Posted : May 30, 2016
Type 2 diabetes is the chronic disease with the most important development in France, and particularly in the Saint-Etienne area due to his specific population.
Different studies showed the interest of screening targeted on high risk population to reduce cardiovascular risks and mortality.
The current screening recommandation is an opportunist targeted screening on population older than 45 years with risk factors by a fasting glucose every 3 years, and a communautaire screening targeted on population older than 45 years suffering precarity with or without risk factors by capillary blood glucose or fasting glucose.
The objective of the Sainté Diabete network is to optimize the screening of diabetics, their follow-up and their treatments. Using a self-administered questionnaire during a medical visit could be a simple, cheap and efficient tool to detect diabetics as soon as possible.
|Condition or disease||Intervention/treatment|
|Type 2 Diabetes||Other: fulfill the self-administered questionnaire|
|Study Type :||Observational|
|Actual Enrollment :||1305 participants|
|Official Title:||Evaluation of the Targeted Screening of Type 2 Diabetes by Capillary Blood Glucose Compared to Current Screening in the Priority Health Area of Saint-Etienne and the Sainté Diabète Network.|
|Study Start Date :||November 2014|
|Primary Completion Date :||March 2015|
|Study Completion Date :||March 2015|
fulfill the self-administered questionnaire.
Other: fulfill the self-administered questionnaire
Patients viewed in a pharmacy or a hospital fulfill the self-administered questionnaire before having a capillary blood glucose measurement.
- Sensitivity of detection of type 2 diabetes [ Time Frame: Day 1 (inclusion day) ]To evaluate the sensitivity (true positive) of detection of type 2 diabetes by a self-administered questionnaire performed in a pharmacy or a hospital compared to capillary blood glucose measurements in the same population from the priority health area of Saint-Etienne.
- Specificity of detection of type 2 diabetes [ Time Frame: Day 1 (inclusion day) ]To evaluate the specificity (true negative) of detection of type 2 diabetes by a self-administered questionnaire performed in a pharmacy or a hospital compared to capillary blood glucose measurements in the same population from the priority health area of Saint-Etienne
- To evaluate the cost of the targeted screening and the screening accessibility to population from the priority health area of Saint-Etienne [ Time Frame: Month 2 ]
- To evaluate the numbers of patients screened by self-administered questionnaire and diagnosed as diabetics using fasting glucose. [ Time Frame: Month 2 ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02440555
|Saint-etienne, France, 42055|
|Study Director:||Christophe BOIS, Pr||Université de Saint-Etienne|